Z-2387-2021Class II
Merge Hemo, Software packages 10.2, 10.3, and 10.4
Merge Healthcare Incorporated / initiated 2021-07-23 / Terminated / root cause: software
Merge Healthcare, Inc. began a recall of Merge Hemo, Software packages 10.2, 10.3, and 10.4 on . FDA classified it as Class II and gives the reason as "The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface". As of , the recall status on record is Terminated, and MDM tags the root cause as software.
Recall record
- Recall number
- Z-2387-2021
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Merge Healthcare Incorporated
- Product
- Merge Hemo, Software packages 10.2, 10.3, and 10.4
- Product code
- DQK Computer, Diagnostic, Programmable
- Reason for recall
- The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface.
- Root cause tag
- software
- FDA root cause
- Under Investigation by firm
- Action
- The firm issued an Urgent Field Safety Notice by email on 07/23/2021. The letter explained the issue and provided a workaround for the safe, continued use of the instrument until a software correction can be made.
- Quantity in commerce
- 326 units
- Distribution
- US distribution
- Product codes and lots
- Version 10.2, UDI (01)00842000100430(10)10.2(11)190612 Version 10.3, UDI (01)00842000100874(10)10.3(11)200330 Version 10.4, UDI (01)00842000100966(10)10.4(11)210428
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2387-2021 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
